GSK

GSK - GSK • Financials

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2016
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2017
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2018
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2021
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2022
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2023
38,608
11,507
-
16%
3.1
16,991
37%
16,340
1.4
8,225
-2,984
-7,181
5,241
0
-2,860
46%
3.8%
12/2024
39,371
8,247
-
8%
1.6
17,155
19%
16,432
2
7,792
-3,742
-5,930
4,051
0
-3,067
95%
4.4%
12/2025
43,929
13,778
-
17%
3.7
22,023
35%
19,249
1.4
9,907
-4,014
-4,955
5,893
-1,852
-3,448
45%
3.5%